Company · DTIL
Precision BioSciences, Inc.
Name as listed on its exchange; filed with the SEC as PRECISION BIOSCIENCES INC.
Nasdaq's symbol directory lists DTIL on Nasdaq as “Precision BioSciences, Inc. - Common Stock”.
In the 12 months to Nov 8, 2026: insiders bought on 3 occasions ($30K); 2 planned-sale notices; 4 filings by holders of 5% or more; 3 company reports (Form 8-K, since May 26, 2026).
All insider filings at the SEC · Appeared in No. 38
Insider trades · SEC Form 4
Those inside the hall
Open-market purchases and sales only. Legs one person filed for one day are combined.
Who traded
- Geno J. Germano bought $16K
- Melinda Brown bought $7K
- Frankel Stanley bought $6K
Every trade (3)
- BUYFrankel Stanley bought $6K
- BUYGeno J. Germano bought $16K
- BUYMelinda Brown bought $7K
Planned sales · SEC Form 144
Notice given
A Form 144 is filed before an insider sells restricted stock. It states an intent; the sale, if it happens, appears later on a Form 4. Every recent notice
- SMITH J. JEFFERSON $9K
- SMITH J. JEFFERSON $72K
Large holders · SEC Schedules 13D and 13G
Five percent and over
Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Every recent 13D and 13G
- Octagon Capital Advisors LP 5.73%
- BlackRock, Inc. 5.01%
- Weinstein Benjamin 4%
- Lynx1 Capital Management LP 5.4%
Company reports · SEC Form 8-K
In its own words
Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.
- Other events Nov 6, 2026
- Regulation FD disclosure; Other events Nov 5, 2026
- Results of operations and financial condition Nov 3, 2026
Sources: SEC EDGAR (Forms 4, 144 and 8-K) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.